MCE 的所有产品仅用作科学研究或药证申报，我们不为任何个人用途提供产品和服务。

Furosemide sodium

CAS No. : 41733-55-5

MCE 站：Furosemide sodium

产品活性：Furosemide sodium 是 Na⁺/K⁺/2Cl^-?(NKCC)，NKCC1 和 NKCC2 共转运蛋白的有效的和具有口服活性抑制剂。Furosemide sodium 也是 GABA_A 受体拮抗剂，对含 α6 受体的选择性是含 α1 受体的 100 倍。Furosemide sodium 用作利尿试剂，用于充血性心力衰竭，高血压和水肿的研究。

研究领域：Membrane Transporter/Ion Channel  |  Neuronal Signaling

作用靶点：NKCC  |  GABA Receptor

In Vitro: Furosemide sodium (500 ?M; 72-96 hours) significantly changes the proliferation rates in MKN45 cells (the poorly differentiated human gastric adenocarcinoma cell line). however, it has no effects on MKN28 cells (the moderately differentiated human gastric adenocarcinoma cell line). The growth rate of MKN45 cells is larger than that of MKN28 cells.
Furosemide sodium (10 ?M, 30 ?M, 100 ?M; 45 min exposure)significantly decreases cation channel activity and [Ca(2+)](i) in human erythrocytes drawn from healthy individuals. Tert-butylhydroperoxide similarly enhances the non-selective cation channels activity, increases [Ca(2+)](i) and triggered cell membrane scrambling, however, the effects is significantly blunted by Furosemide sodium again.

In Vivo: Furosemide sodium (intraperitoneal injection; 100 mg/kg; single dose) is injected after kanamycin (KM) (1000 mg/kg) to creat a deaf mouse model in C57BL/6 mouse. After injection, hearing loss and cochlear hair cell damage are evaluated on day 1, day 2 and day 3, respectively. The hearing is markedly deteriorated even from the next day (Day-1 group), OHCs (outer hair cell) morphology of apical, middle and basal turns are disorganized in mice on day3.

相关产品：Drug Repurposing Compound Library Plus  |  FDA-Approved Drug Library Plus  |  FDA-Approved Drug Library Mini  |  Bioactive Compound Library Plus  |  Membrane Transporter/Ion Channel Compound Library  |  Neuronal Signaling Compound Library  |  FDA-Approved Drug Library  |  Anti-Cancer Compound Library  |  Drug Repurposing Compound Library  |  Orally Active Compound Library  |  Neurotransmitter Receptor Compound Library  |  FDA Approved & Pharmacopeial Drug Library  |  Anti-Alzheimer’s Disease Compound Library  |  Drug-Induced Liver Injury (DILI) Compound Library  |  (+)-Bicuculline  |  Aminooxyacetic acid hemihydrochloride  |  Sodium dichloroacetate  |  Gabazine  |  Riluzole  |  γ-Aminobutyric acid  |  Picrotoxin  |  Propofol  |  Bumetanide  |  Vigabatrin  |  (R)-Baclofen  |  CGP52432  |  Furosemide  |  Etomidate  |  Flumazenil  |  Dihydroergotoxine mesylate  |  Ginkgolide A  |  Methionine  |  Emamectin Benzoate  |  Etifoxine  |  Isoguvacine hydrochloride  |  Jujuboside A  |  Topiramate  |  Azosemide  |  Lotilaner  |  (-)-Securinine  |  alpha-Asarone

品牌介绍:
•   MCE (MedChemExpress) 拥有数百种全球独家化合物，我们致力于为全球科研客户提供*新*全的高品质小分子活性化合物；
•   10,000 多种高选择性抑制剂、激动剂涉及各热门信号通路及疾病领域；
•   设有专业的实验中心和严格的质控、验证体系；
•   提供 LC/MS、NMR、HPLC、手性分析、元素分析等各项质检报告，确保产品的高纯度、高品质；
•   产品的生物活性多经各国客户实验验证；
•   Nature, Cell, Science 等多种期刊及制药收录了MCE客户的科研成果；
•   专业团队跟踪*新的制药及生命科学研究进展，为您提供全球*新的活性化合物；
•   与世界各大制药公司及知名科研机构建立了长期的合作。